Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T17:21:44.808Z Has data issue: false hasContentIssue false
  • English
  • Français

Malignant hyperpyrexia syndrome in combined treatment

Published online by Cambridge University Press:  02 January 2018

E. F. Staufenberg  and
D. Tantam
E. F. Staufenberg
Affiliation:
Department of Psychiatry, University of Manchester, Withington Hospital, West Didsbury, Manchester M20 8LR
D. Tantam
Affiliation:
Department of Psychiatry, University of Manchester, Withington Hospital, West Didsbury, Manchester M20 8LR
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 154 , Issue 4 , April 1989 , pp. 577 - 578
Copyright
Copyright © Royal College of Psychiatrists, 1989 

References

Grahame-Smith, D. G. (1970) Studies in vivo on the relationship between brain tryptophan and brain 5-HT synthesis. Journal of Neurochemistry, 18, 1053–1071.Google Scholar
Gribb, W. R. G. (1988) NMS in striatonigral degeneration. British Journal of Psychiatry, 153, 254–255.Google Scholar
Henderson, & Wooten, (1981) NMS: a pathogenetic role for dopamine receptor blockade? Neurology, 31, 132–137.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.